title: ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
abstract: In clinical exome and genome sequencing, there is a potential for the recognition and reporting of incidental or secondary findings unrelated to the indication for ordering the sequencing but of medical value for patient care. The American College of Medical Genetics and Genomics (ACMG) recently published a policy statement on clinical sequencing that emphasized the importance of alerting the patient to the possibility of such results in pretest patient discussions, clinical testing, and reporting of results. The ACMG appointed a Working Group on Incidental Findings in Clinical Exome and Genome Sequencing to make recommendations about responsible management of incidental findings when patients undergo exome or genome sequencing. This Working Group conducted a year-long consensus process, including an open forum at the 2012 Annual Meeting and review by outside experts, and produced recommendations that have been approved by the ACMG Board. Specific and detailed recommendations, and the background and rationale for these recommendations, are described herein. The ACMG recommends that laboratories performing clinical sequencing seek and report mutations of the specified classes or types in the genes listed here. This evaluation and reporting should be performed for all clinical germline (constitutional) exome and genome sequencing, including the "normal" of tumor-normal subtractive analyses in all subjects, irrespective of age but excluding fetal samples. We recognize that there are insufficient data on penetrance and clinical utility to fully support these recommendations, and we encourage the creation of an ongoing process for updating these recommendations at least annually as further data are collected.
authors.affiliation: Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. rcgreen@genetics.med.harvard.edu
authors.forename: Robert C
authors.initials: RC
authors.lastname: Green
authors.forename: Jonathan S
authors.initials: JS
authors.lastname: Berg
authors.forename: Wayne W
authors.initials: WW
authors.lastname: Grody
authors.forename: Sarah S
authors.initials: SS
authors.lastname: Kalia
authors.forename: Bruce R
authors.initials: BR
authors.lastname: Korf
authors.forename: Christa L
authors.initials: CL
authors.lastname: Martin
authors.forename: Amy L
authors.initials: AL
authors.lastname: McGuire
authors.forename: Robert L
authors.initials: RL
authors.lastname: Nussbaum
authors.forename: Julianne M
authors.initials: JM
authors.lastname: O'Daniel
authors.forename: Kelly E
authors.initials: KE
authors.lastname: Ormond
authors.forename: Heidi L
authors.initials: HL
authors.lastname: Rehm
authors.forename: Michael S
authors.initials: MS
authors.lastname: Watson
authors.forename: Marc S
authors.initials: MS
authors.lastname: Williams
authors.forename: Leslie G
authors.initials: LG
authors.lastname: Biesecker
mesh_terms: D059472:Exome; D005826:Genetics, Medical; D015894:Genome, Human; D006801:Humans; D033162:Incidental Findings; D057240:Patient Preference; D019683:Penetrance